Literature DB >> 27957096

Clinical Relevance Of Systematic CRT Device Optimization.

Maurizio Lunati1, Giovanni Magenta1, Giuseppe Cattafi1, Antonella Moreo1, Giacomo Falaschi2, Danilo Contardi2, Emanuela Locati1.   

Abstract

Cardiac Resynchronization Therapy (CRT) is known as a highly effective therapy in advanced heart failure patients with cardiac dyssynchrony. However, still one third of patients do not respond (or sub-optimally respond) to CRT. Among the many contributors for the high rate of non-responders, the lack of procedures dedicated to CRT device settings optimization (parameters to regulate AV synchrony and VV synchrony) is known as one of the most frequent. The most recent HF/CRT Guidelines do not recommend to carry-out optimization procedures in every CRT patient; they simply state those procedures "could be useful in selected patients", even though their role in improving response has not been proven. Echocardiography techniques still remain the gold-standard reference method to the purpose of CRT settings optimization. However, due to its severe limitations in the routine of CRT patients management (time and resource consuming, scarce reproducibility, inter and intra-operator dependency), echocardiography optimization is widely under-utilized in the real-world of CRT follow-up visits. As a consequence, device-based techniques have been developed to by-pass the need for repeated echo examinations to optimize CRT settings. In this report the available device-based optimization techniques onboard on CRT devices are shortly reviewed, with a specific focus on clinical outcomes observed in trials comparing these methods vs. clinical practice or echo-guided optimization methods. Particular emphasis is dedicated to hemodynamic methods and automaticity of optimization algorithms (making real the concept of "ambulatory CRT optimization"). In fact a hemodynamic-based approach combined with a concept of frequent re-optimization has been associated - although retrospectively - with a better clinical outcome on the long-term follow-up of CRT patients. Large randomized trials are ongoing to prospectively clarify the impact of automatic optimization procedures.

Entities:  

Year:  2014        PMID: 27957096      PMCID: PMC5135253          DOI: 10.4022/jafib.1077

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  21 in total

Review 1.  Optimization of cardiac resynchronization therapy: importance of programmed parameters.

Authors:  Frank A Cuoco; Michael R Gold
Journal:  J Cardiovasc Electrophysiol       Date:  2011-12-21

Review 2.  Optimization of the atrioventricular delay in sequential and biventricular pacing: physiological bases, critical review, and new purposes.

Authors:  Lanfranco Antonini; Antonio Auriti; Vincenzo Pasceri; Antonella Meo; Christian Pristipino; Antonio Varveri; Salvatore Greco; Massimo Santini
Journal:  Europace       Date:  2012-02-06       Impact factor: 5.214

3.  Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.

Authors:  Kenneth A Ellenbogen; Michael R Gold; Timothy E Meyer; Ignacio Fernndez Lozano; Suneet Mittal; Alan D Waggoner; Bernd Lemke; Jagmeet P Singh; Francis G Spinale; Jennifer E Van Eyk; Jeffrey Whitehill; Stanislav Weiner; Maninder Bedi; Joshua Rapkin; Kenneth M Stein
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

4.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

5.  2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.

Authors:  Jean-Claude Daubert; Leslie Saxon; Philip B Adamson; Angelo Auricchio; Ronald D Berger; John F Beshai; Ole Breithard; Michele Brignole; John Cleland; David B Delurgio; Kenneth Dickstein; Derek V Exner; Michael Gold; Richard A Grimm; David L Hayes; Carsten Israel; Christophe Leclercq; Cecilia Linde; Joann Lindenfeld; Bela Merkely; Lluis Mont; Francis Murgatroyd; Frits Prinzen; Samir F Saba; Jerold S Shinbane; Jagmeet Singh; Anthony S Tang; Panos E Vardas; Bruce L Wilkoff; Jose Luis Zamorano
Journal:  Heart Rhythm       Date:  2012-09       Impact factor: 6.343

6.  An implantable intracardiac accelerometer for monitoring myocardial contractility. The Multicenter PEA Study Group.

Authors:  A F Rickards; T Bombardini; G Corbucci; G Plicchi
Journal:  Pacing Clin Electrophysiol       Date:  1996-12       Impact factor: 1.976

7.  Contributions of a hemodynamic sensor embedded in an atrial lead in a porcine model.

Authors:  Pierre Bordachar; Stephane Garrigue; Philippe Ritter; Sylvain Ploux; Louis Labrousse; Cyril Casset; Michel Haissaguerre; Pierre Dos Santos
Journal:  J Cardiovasc Electrophysiol       Date:  2010-10-13

8.  Four chamber pacing in dilated cardiomyopathy.

Authors:  S Cazeau; P Ritter; S Bakdach; A Lazarus; M Limousin; L Henao; O Mundler; J C Daubert; J Mugica
Journal:  Pacing Clin Electrophysiol       Date:  1994-11       Impact factor: 1.976

9.  Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.

Authors:  Wilfried Mullens; Richard A Grimm; Tanya Verga; Thomas Dresing; Randall C Starling; Bruce L Wilkoff; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2009-03-03       Impact factor: 24.094

Review 10.  Cardiac resynchronisation therapy optimisation strategies: systematic classification, detailed analysis, minimum standards and a roadmap for development and testing.

Authors:  S M Afzal Sohaib; Zachary I Whinnett; Kenneth A Ellenbogen; Christoph Stellbrink; T Alexander Quinn; Margot D Bogaard; Pierre Bordachar; Berry M van Gelder; Irene E van Geldorp; Cecilia Linde; Mathias Meine; Frits W Prinzen; Robert G Turcott; Henry M Spotnitz; Dan Wichterle; Darrel P Francis
Journal:  Int J Cardiol       Date:  2013-10-29       Impact factor: 4.164

View more
  3 in total

1.  Programming Cardiac Resynchronization Therapy for Electrical Synchrony: Reaching Beyond Left Bundle Branch Block and Left Ventricular Activation Delay.

Authors:  Niraj Varma; David O'Donnell; Mohammed Bassiouny; Philippe Ritter; Carlo Pappone; Jan Mangual; Daniel Cantillon; Nima Badie; Bernard Thibault; Brian Wisnoskey
Journal:  J Am Heart Assoc       Date:  2018-02-06       Impact factor: 5.501

2.  Frequency and causes of QRS prolongation during exercise electrocardiogram testing in biventricular paced patients with heart failure.

Authors:  Brett D Atwater; Kasper Emerek; Zak Loring; Christoffer Polcwiartek; Kevin P Jackson; Daniel J Friedman
Journal:  HeartRhythm Case Rep       Date:  2020-05-07

3.  Real-World Economic Burden Among Patients With And Without Heart Failure Worsening After Cardiac Resynchronization Therapy.

Authors:  Eugene S Chung; John Rickard; Xiaoxiao Lu; Maral DerSarkissian; Miriam L Zichlin; Hoi Ching Cheung; Natalia Swartz; Alexandra Greatsinger; Mei S Duh
Journal:  Adv Ther       Date:  2020-11-03       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.